Author Question: Which of the following demonstrates the similarities of a repeated-measures analysis of variance for ... (Read 64 times)

Brittanyd9008

  • Hero Member
  • *****
  • Posts: 500
Which of the following demonstrates the similarities of a repeated-measures analysis of variance for two trials and a t test for related means?
 
  a. F = t2
  b. F2 = t
  c. F = t
  d. F = 2t

Question 2

In a typical learning experiment, a carry-over effect is
 
  a. something to be avoided at all cost.
  b. a necessary evil.
  c. unlikely to be present.
  d. what you are actually studying.



lindahyatt42

  • Sr. Member
  • ****
  • Posts: 322
Answer to Question 1

A

Answer to Question 2

D



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question


 

Did you know?

In the United States, there is a birth every 8 seconds, according to the U.S. Census Bureau's Population Clock.

Did you know?

Signs and symptoms of a drug overdose include losing consciousness, fever or sweating, breathing problems, abnormal pulse, and changes in skin color.

Did you know?

An identified risk factor for osteoporosis is the intake of excessive amounts of vitamin A. Dietary intake of approximately double the recommended daily amount of vitamin A, by women, has been shown to reduce bone mineral density and increase the chances for hip fractures compared with women who consumed the recommended daily amount (or less) of vitamin A.

Did you know?

Over time, chronic hepatitis B virus and hepatitis C virus infections can progress to advanced liver disease, liver failure, and hepatocellular carcinoma. Unlike other forms, more than 80% of hepatitis C infections become chronic and lead to liver disease. When combined with hepatitis B, hepatitis C now accounts for 75% percent of all cases of liver disease around the world. Liver failure caused by hepatitis C is now leading cause of liver transplants in the United States.

Did you know?

The first monoclonal antibodies were made exclusively from mouse cells. Some are now fully human, which means they are likely to be safer and may be more effective than older monoclonal antibodies.

For a complete list of videos, visit our video library